Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Statistics in Medicine
|
April 13, 2012
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer
John Whitehead, Helene Thygesen, Thomas Jaki, et al.
Epilepsy & Behavior : E&B
|
March 1, 2003
Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis
Martin J. Brodie, Stephen J. Wroe, Andrew D. P. Dean, et al.
Journal of Clinical Pathology
|
July 24, 2017
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12
Simon John Whitehead, Clare Ford, Rousseau Mariano Gama, et al.
BMJ Open
|
October 18, 2015
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
Sudeep P Pushpakom, Claire Taylor, Ruwanthi Kolamunnage-Dona, et al.
Plos Medicine
|
April 16, 2015
Evaluating clinical trial designs for investigational treatments of Ebola virus disease
Ben S Cooper, Maciej F Boni, Wirichada Pan-ngum, et al.
Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology
|
January 30, 2022
Why is it so difficult to study magnetic compass orientation in murine rodents?
John Phillips, Rachel Muheim, Michael Painter, et al.
Plos One
|
September 10, 2016
Experimental Treatment of Ebola Virus Disease with Brincidofovir
Jake Dunning, Stephen B Kennedy, Annick Antierens, et al.
Rheumatology (Oxford, England)
|
July 29, 2024
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis
Charalampia Papadopoulou, Neil Martin, Nadia Rafiq, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Lancet (London, England)
|
November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issues
Clement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Statistics in Medicine
|
April 13, 2012
A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer
John Whitehead, Helene Thygesen, Thomas Jaki, et al.
Epilepsy & Behavior : E&B
|
March 1, 2003
Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis
Martin J. Brodie, Stephen J. Wroe, Andrew D. P. Dean, et al.
Journal of Clinical Pathology
|
July 24, 2017
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12
Simon John Whitehead, Clare Ford, Rousseau Mariano Gama, et al.
BMJ Open
|
October 18, 2015
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
Sudeep P Pushpakom, Claire Taylor, Ruwanthi Kolamunnage-Dona, et al.
Plos Medicine
|
April 16, 2015
Evaluating clinical trial designs for investigational treatments of Ebola virus disease
Ben S Cooper, Maciej F Boni, Wirichada Pan-ngum, et al.
Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology
|
January 30, 2022
Why is it so difficult to study magnetic compass orientation in murine rodents?
John Phillips, Rachel Muheim, Michael Painter, et al.
Plos One
|
September 10, 2016
Experimental Treatment of Ebola Virus Disease with Brincidofovir
Jake Dunning, Stephen B Kennedy, Annick Antierens, et al.
Rheumatology (Oxford, England)
|
July 29, 2024
Elicitation of expert prior opinion to design the BARJDM trial in juvenile dermatomyositis
Charalampia Papadopoulou, Neil Martin, Nadia Rafiq, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Lancet (London, England)
|
November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issues
Clement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Page
of 8